Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes

<jats:p>Diabetic kidney disease (DKD) is a key determinant of morbidity and mortality in patients with type 1 diabetes (T1D). Identifying factors associated with early glomerular filtration rate (GFR) decline in T1D is important in prevention or early intervention for DKD. This study investigated whether phosphate metabolism, including fibroblast growth factor 23 (FGF23) is associated with the kidney function of patients with T1D. We randomly recruited 118 patients with T1D with a normal or mildly impaired kidney function [chronic kidney disease (CKD) stages of G1/G2, A1/A2], and measured their serum FGF23 levels. Serum FGF23 was significantly negatively associated with the estimated GFR (eGFR) (<jats:italic>r</jats:italic> = -0.292, <jats:italic>P</jats:italic> = 0.0016), but not urinary albumin creatinine ratio (UACR), and positively associated with serum phosphate (Pi; <jats:italic>r</jats:italic> = 0.273, <jats:italic>P</jats:italic> = 0.0027). Serum FGF23 increased with decreasing eGFR quartiles (<jats:italic>P</jats:italic> for linear trend = 0.0371), while FGF23 was modestly higher in the higher quartiles of UACR (not statistically significant). The multiple linear regression analysis also showed a significant inverse association between FGF23 and eGFR (Model 1: <jats:italic>β</jats:italic> = -0.149, <jats:italic>P</jats:italic> = 0.0429; Model 2: <jats:italic>β</jats:italic> = -0.141, <jats:italic>P</jats:italic> = 0.0370). The association remained significant after adjustment for Pi. We identified that FGF23 was inversely associated with the eGFR in T1D patients with a normal or mildly impaired kidney function.</jats:p>